Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma

被引:0
|
作者
Xuanli Xu
Rongrong Li
Lin Zhang
Guopei Zhu
Dandan Ren
Lijia Wu
Xiaoli Gong
机构
[1] the Ninth People’s Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Department of Oral and Maxillofacial Head and Neck Oncology
[2] Genecast Biotechnology Co.,undefined
[3] Ltd,undefined
来源
Diagnostic Pathology | / 16卷
关键词
Head and neck squamous cell carcinoma; Immunotherapy; Prognosis; Efficacy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] TMErisk score: A tumor microenvironment-based model for predicting prognosis and immunotherapy in patients with head and neck squamous cell carcinoma
    Li, Yu
    Pan, Xiaozhou
    Luo, Wenwei
    Gamalla, Yaser
    Ma, Zhan
    Zhou, Pei
    Dai, Chunfu
    Han, Dingding
    HELIYON, 2024, 10 (11)
  • [42] Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
    Li, Xia
    Fang, Qigen
    Du, Wei
    Zhang, Xu
    Dai, Liyuan
    Qiao, Yongming
    BMC CANCER, 2021, 21 (01)
  • [43] Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
    Xia Li
    Qigen Fang
    Wei Du
    Xu Zhang
    Liyuan Dai
    Yongming Qiao
    BMC Cancer, 21
  • [44] Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
    Meliante, Piero Giuseppe
    Zoccali, Federica
    de Vincentiis, Marco
    Ralli, Massimo
    Petrella, Carla
    Fiore, Marco
    Minni, Antonio
    Barbato, Christian
    DIAGNOSTICS, 2023, 13 (05)
  • [45] The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck
    Scheff, Nicole N.
    Nilsen, Marci L.
    Li, Jinhong
    Harris, Alexandria L.
    Acharya, Rajesh
    Swartz, Andrew
    Hsieh, Ronan W.
    Anderson, Jennifer L.
    Ferris, Robert L.
    V. Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan P.
    ORAL ONCOLOGY, 2023, 140
  • [46] A pyroptosis-related lncRNA risk model for the prediction of prognosis and immunotherapy response in head and neck squamous cell carcinoma
    Ren, Jingyuan
    Yan, Bingrui
    Wang, Xurui
    Wang, Yifei
    Li, Qiuying
    Sun, Yanan
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Identification of Exosome-Related Genes Associated with Prognosis and Immune Infiltration Features in Head-Neck Squamous Cell Carcinoma
    You, Yuanhe
    Du, Zhong
    Xu, Guisong
    Tian, Zhuowei
    Xiao, Meng
    Wang, Yanan
    BIOMOLECULES, 2023, 13 (06)
  • [48] Molecular subtype identification and prognosis stratification based on golgi apparatus-related genes in head and neck squamous cell carcinoma
    Aichun Zhang
    Xiao He
    Chen Zhang
    Xuxia Tang
    BMC Medical Genomics, 17
  • [49] Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
    Li, Qun
    Shen, Zhisen
    Shen, Yi
    Deng, Hongxia
    Shen, Yiming
    Wang, Jianing
    Zhan, Guowen
    Zhou, Chongchang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (06)
  • [50] Molecular subtype identification and prognosis stratification based on golgi apparatus-related genes in head and neck squamous cell carcinoma
    Zhang, Aichun
    He, Xiao
    Zhang, Chen
    Tang, Xuxia
    BMC MEDICAL GENOMICS, 2024, 17 (01)